3rd Cell Therapy for Autoimmune Disease Summit

Power Targeted Therapeutic and Clinical Breakthroughs Across Different Autoimmune Cell Therapies with Proven Safety, Sustained Efficacy, and Greater Patient Access to Redefine Chronic Care of Autoimmune Diseases.

Ever since cell therapies demonstrated potential in lupus and beyond, focus has shifted from oncology to advancing the first approved autoimmune cell therapy to market.

The 3rd Cell Therapy for Autoimmune Disease Summit returns at a transformative moment for this field, as autoimmune therapies stand poised to lead the next frontier of cell therapy innovation. As the only forum spotlighting breakthroughs across CAR-T, Treg, NK and in vivo cell therapies, this is your opportunity to gain end-to-end insights to navigate the dynamic, high-velocity road to market.

Uncover first-hand experiences from industry titans including Cabaletta Bio, Kyverna Therapeutics, Umoja Biopharma, Cartesian Therapeutics, Century Therapeutics, Artiva Biotherapeutics and Novartis, to accelerate your therapeutic progression and remain ahead of your peers.

From target selection and IND preparation to clinical trial design, patient recruitment, and long-term data, this year's edition will empower you to translate clinical promise into real breakthroughs.